Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

LIAISON® CMV IgG and LIAISON® CMV IgG Serum Control Set

K-Number: K162969 · 2017-01-06

Decision Date2017-01-06
Product CodeLFZ
Advisory CommitteeMI
DecisionSubstantially Equivalent

Device Summary

LIAISON® CMV IgG and LIAISON® CMV IgG Serum Control Set is a medical device manufactured by DiaSorin, Inc.. It received FDA 510(k) clearance on 2017-01-06 under approval number K162969. The device is classified under product code LFZ. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the LIAISON® CMV IgG and LIAISON® CMV IgG Serum Control Set?

LIAISON® CMV IgG and LIAISON® CMV IgG Serum Control Set is a medical device that received FDA 510(k) clearance on 2017-01-06. It is manufactured by DiaSorin, Inc.. The 510(k) number is K162969.

When was LIAISON® CMV IgG and LIAISON® CMV IgG Serum Control Set approved by the FDA?

LIAISON® CMV IgG and LIAISON® CMV IgG Serum Control Set received FDA 510(k) clearance on 2017-01-06, under approval number K162969.

What company makes LIAISON® CMV IgG and LIAISON® CMV IgG Serum Control Set?

LIAISON® CMV IgG and LIAISON® CMV IgG Serum Control Set is manufactured by DiaSorin, Inc..

What is the FDA product code for LIAISON® CMV IgG and LIAISON® CMV IgG Serum Control Set?

The FDA product code for LIAISON® CMV IgG and LIAISON® CMV IgG Serum Control Set is LFZ.

Related Clinical Trials

Other Devices by DiaSorin, Inc.

View all 41 devices →

Related Devices (Code: LFZ)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.